Copy
Q2, 2021 —  Welcome to the latest Q2i newsletter! Since our last update we've achieved a significant milestone with our OARS solution which opens up even more opportunities for the platform. After a successful completion of Phase I, Q2i has been awarded a Phase II NIH research grant in partnership with the UCLA School of Medicine to deploy and validate our OARS technology to improve the success of MOUD in primary care. OARS enables better management and support of MOUD through digital engagement tools and Telehealth capabilities. It’s a busy and exciting time as the evidence of the efficacy of our solutions is building and we are rolling out the OARS platform to primary care providers, addiction treatment centers, FQHCs and emergency departments.

Regards,

Steve Jenkins
CEO, Q2i

Q2i's OARS software application moves to Phase II of National Institute of Health (NIH) clinical trial which will evaluate the application's efficacy in improving Opioid Use Disorder treatment

Along with our Academic Partner UCLA, Q2i has been awarded Phase II of an NIH grant in which six healthcare organization's primary care providers and their OUD patients will utilize the OARS technology.

Dr. Steven Shoptaw leading the research team that is evaluating the OARS software application. Dr. Shoptaw said, “The availability and access gap for OUD patients seeking treatment is a real issue that needs addressing. Equipping and empowering primary care providers and their healthcare organizations with technology that both connects with and extends their EHR, could be key to increasing patients’ abilities to start and retain in MAT. A specialized application may improve patient engagement and treatment retention compared to today’s generic EHR patient portals, where SUD patient uptake is low and retention is even worse.”
 
Read the Press Release

Q2i's and our solutions will be on display at the 2021 ASAM Virtual Conference from April 22nd - 24th where will be showcasing our OARS and OARS+Contingency Management solution. We hope to see you there!

View Q2i's ASAM Page

Q2i's OARS+Contingency Management solution will be on display at the 2021 SAEM Virtual Meeting from May 11th - 14th

Q2i's OARS+Contingency Management solution will be on display at the 2021 SAEM Virtual Conference. For more information on the SAEM Virtual Conference click the link below.
View SAEM Virtaul Meeting Details

Q2i's OARS software application will be on display at the 2021 College on Problems of Drug Dependence (CPDD) Annual Scientific Meeting from June 21st - 24th  

Q2i's OARS solution will be on display at the 2021 CPDD Annual Scientific Forum. For more information on the CPDD forum click the link below.
View Annual Scientific Meeting Details

Expanding Telehealth Capabilities of OARS Allows Q2i to Extend Added Benefits to Patients Outside the Traditional Treatment Setting

Telehealth helps individuals manage their care and health services they receive by overcoming barriers of traditional health care. Telehealth can increase access to healthcare by overcoming geographical and physical barriers such as distance, reliable transportation, time, etc.

During the COVID-19 pandemic, Telehealth has become an essential tool to provide care to patients while keeping everyone safe. Due to COVID-19, state and federal regulations regarding Telehealth have been updated to support the implementation or expansion of Telehealth by providers and healthcare organizations.
View on Website
OARS - Opioid Addiction Recovery Support is used by providers of MAT programs to improve insight into a patient’s recovery progress and promotes ownership and adherence to treatment plans. OARS also provides extensive tools to support patients with recovery from Opioid Use Disorder. Using OARS patients are better connected to, and supported by their healthcare team throughout their recovery journey.

 

This extended connection and support fosters conditions for:

  • Improved ownership and adherence to treatment plans
  • Increased patient engagement
  • Fewer relapses
  • Decreased in-patient admissions/ re-admissions
  • Reduced program dropouts
  • Reduced ER visits
Click Here to Learn More
Copyright © 2021 Q2i, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp